Integrative Chinese and western medicine on atherosclerosis of coronary heart disease: what are the new control strategies?

被引:4
作者
Yue Liu [1 ,2 ]
Yuerong Jiang [1 ,2 ]
Jingchun Zhang [1 ,2 ]
Dazhuo Shi [1 ,2 ]
机构
[1] Department of Cardiovascular Diseases,Xiyuan Hospital of China Academy of Chinese Medical Sciences
[2] China Heart Institute of Chinese Medicine
关键词
D O I
暂无
中图分类号
R541.4 [冠状动脉(粥样)硬化性心脏病(冠心病)];
学科分类号
1002 ; 100201 ;
摘要
How to control and prevent atherosclerosis(AS) remains a global issue that needs to be deeply discussed. The innovation concept of AS and coronary heart disease(CHD) in western medicine provides a good opportunity to develop the traditional Chinese medicine etiology and new control strategies accordingly. This article reviewed and refined the updated control strategies of AS of CHD integrated Chinese and western medicine based on the innovation concept and therapeutic guideline of AS and CHD during the last 10 years.
引用
收藏
页码:1091 / 1096
页数:6
相关论文
共 24 条
[1]  
Complementary and alternative medicine: Is it possible to be mainstream?.[J].Hao Xu;Ke-ji Chen.Chinese Journal of Integrative Medicine.2012, 6
[2]  
Atherosclerosis: An Integrative East-West Medicine Perspective.[J].Hao Xu;Dazhuo Shi;Keji Chen;Myeong Soo Lee.Evidence-Based Complementary and Alternative Medicine.2012,
[3]  
Chinese Herb and Formulas for Promoting Blood Circulation and Removing Blood Stasis and Antiplatelet Therapies.[J].Yue Liu;Hui-Jun Yin;Da-zhuo Shi;Ke-ji Chen;Myeong Soo Lee.Evidence-Based Complementary and Alternative Medicine.2012,
[4]  
Atherosclerosis; vascular aging and therapeutic strategies.[J].Yue Liu;Ke-ji Chen.Chinese Journal of Integrative Medicine.2012, 2
[5]   Integrative medicine models in contemporary primary health care [J].
Templeman, Kate ;
Robinson, Anske .
COMPLEMENTARY THERAPIES IN MEDICINE, 2011, 19 (02) :84-92
[6]  
Making evidence-based decisions in the clinical practice of integrative medicine.[J].Hao Xu;Ke-ji Chen.Chinese Journal of Integrative Medicine.2010, 6
[7]   Antiplatelet and antithrombotic activities of salvianolic acid A [J].
Fan, Hua-Ying ;
Fu, Feng-Hua ;
Yang, Ming-Yan ;
Xu, Hui ;
Zhang, Ai-Hong ;
Liu, Ke .
THROMBOSIS RESEARCH, 2010, 126 (01) :E17-E22
[8]   Treating Arteries Instead of Risk Factors A Paradigm Change in Management of Atherosclerosis [J].
Spence, J. David ;
Hackam, Daniel G. .
STROKE, 2010, 41 (06) :1193-1199
[9]   Ginkgo biloba extract improves coronary artery circulation in patients with coronary artery disease:: Contribution of plasma nitric oxide and endothelin-1 [J].
Wu, Yu-Zhou ;
Li, Shu-Qin ;
Zu, Xiu-Guang ;
Du, Jun ;
Wang, Feng-Fei .
PHYTOTHERAPY RESEARCH, 2008, 22 (06) :734-739
[10]   From vulnerable plaque to vulnerable patient - A call for new definitions and risk assessment strategies: Part II [J].
Naghavi, M ;
Libby, P ;
Falk, E ;
Casscells, SW ;
Litovsky, S ;
Rumberger, J ;
Badimon, JJ ;
Stefanadis, C ;
Moreno, P ;
Pasterkamp, G ;
Fayad, Z ;
Stone, PH ;
Waxman, S ;
Raggi, P ;
Madjid, M ;
Zarrabi, A ;
Burke, A ;
Yuan, C ;
Fitzgerald, PJ ;
Siscovick, DS ;
de Korte, CL ;
Aikawa, M ;
Airaksinen, KEJ ;
Assmann, G ;
Becker, CR ;
Chesebro, JH ;
Farb, A ;
Galis, ZS ;
Jackson, C ;
Jang, IK ;
Koenig, W ;
Lodder, RA ;
March, K ;
Demirovic, J ;
Navab, M ;
Priori, SG ;
Rekhter, MD ;
Bahr, R ;
Grundy, SM ;
Mehran, R ;
Colombo, A ;
Boerwinkle, E ;
Ballantyne, C ;
Insull, W ;
Schwartz, RS ;
Vogel, R ;
Serruys, PW ;
Hansson, GK ;
Faxon, DP ;
Kaul, S .
CIRCULATION, 2003, 108 (15) :1772-1778